Policy | February 24, 2023
National Health Authority facilitating Quick OPD registration in 365 hospitals
More than 5 lakh patients availed the benefit of queue-less OPD registration using this service
More than 5 lakh patients availed the benefit of queue-less OPD registration using this service
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
This is the fourth facility from the company to receive this registration
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
The company also plans to register the similar range of products in the neighbouring countries.
NUFYMCO BLA has been approved by the USFDA
The upcoming trials will evaluate both active and chronic TED in randomized, double-blind, placebo-controlled studies
The study also showed a clear dose-dependent trend, with the 75 mg QD group outperforming the 50 mg QD cohort
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Dr Reddy’s will pay Immutep US$ 20 million upfront and could deliver as much as US$ 349.5 million in regulatory and commercial milestones
Subscribe To Our Newsletter & Stay Updated
